Market Tracker

09/27 5:16pm ET

Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

26.58
Delayed Data
As of 3:59pm ET
 +0.72 / +2.78%
Today’s Change
9.51
Today|||52-Week Range
26.64
+97.77%
Year-to-Date
No recent news for Supernus Pharmaceuticals Inc.

Today’s Trading

Previous close25.86
Today’s open25.88
Day’s range25.76 - 26.64
Volume627,877
Average volume (3 months)566,503
Market cap$1.3B
Dividend yield--
Data as of 3:59pm ET, 09/27/2016

Growth & Valuation

Earnings growth (last year)-12.50%
Earnings growth (this year)+155.36%
Earnings growth (next 5 years)+50.00%
Revenue growth (last year)+18.34%
P/E ratio53.2
Price/Sales4.76
Price/Book10.66

Competitors

 Today’s
change
Today’s
% change
TXMDTherapeuticsMD Inc+0.18+2.75%
CEMPCempra Inc+1.31+5.30%
PTLAPortola Pharmaceutic...+0.38+1.66%
PCRXPacira Pharmaceutica...+0.46+1.31%
Data as of 4:00pm ET, 09/27/2016

Financials

Next reporting dateNovember 8, 2016
EPS forecast (this quarter)$0.19
Annual revenue (last year)$144.4M
Annual profit (last year)$14.0M
Net profit margin9.70%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, Director &
Secretary
Jack A. Khattar
CFO, Vice President &
Head-Investor Relations
Gregory S. Patrick
Corporate headquarters
Rockville, Maryland

Forecasts